• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

FDA Hiring Initiative: Generic Drug User Fee Amendments of 2012 (GDUFA)

 

 

 

  FDA HIRING FAIR

 

JULY 18, 2014

 

  ON-SITE at the White Oak Campus

 

  in Silver Spring, MD

 

 

REGISTRATION IS CLOSED.


Please send all questions to:
 
 HCTactions@fda.hhs.gov   

 

 

Due to the high volume of registrants,

we will not be accepting walk-ins.

 

 

 

Generic Drugs

What is GDUFA?

On July 9, 2012, the Generic Drug User Fee Amendments of 2012 (GDUFA) was signed into law. GDUFA is designed to speed access to safe and effective generic drugs to the public and reduce costs to industry.

Industry will now pay user fees to supplement the costs of reviewing generic drug applications and inspecting facilities.

These additional resources will enable the FDA to reduce a current backlog of pending drug applications, cut the average time required to review them for safety, and increase risk-based inspections.

GDUFA will also enhance global supply chain safety by requiring generic drug facilities/sites worldwide to self-identify and meet FDA standards for safety, purity and effectiveness. 

  

 

   View a Recording of the OGD Virtual Hiring Event
 

GS Series

Occupation

Vacancy Announcements

0301OPEN
0601OPEN
0301COMING SOON
0301OmbudsmanCOMING SOON
101COMING SOON
0301OPEN
0343COMING SOON
0301COMING SOON
1515CLOSED
0602

CLOSED

301

Policy Analyst

CLOSED

0403/0660/1320

Interdisciplinary Scientist – ORA

CLOSED

1412

Technical Information Specialist

CLOSED

0610

Nurse Consultant

OPEN

0405

Pharmacologist

OPEN 

0403

Microbiologist

OPEN

1320

Chemist

OPEN

0893

Chemical Engineer

CLOSED

0696

Consumer Safety Officer

OPEN 

0696

Consumer Safety Officer - ORA

COMING SOON

0660

Pharmacist

OPEN

0602

Medical Officer

OPEN

1515

Operations Research Analyst

COMING SOON

0401/0403/1320

Interdisciplinary  Scientist

CLOSED

0301

Regulatory Counsel

COMING SOON

 

 

 

 

 

 


 

-